Neuropsychopharmacology - Table of Contents alert Volume 41 Issue 2

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 41, Issue 2 (January 2016) In this issue Commentary Circumspective Original Articles Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Commentary Top Circumspectives: Cannabis and Psychiatric Illness: Blunt Thoughts Markus Heilig and William A Carlezon, Neuropsychopharmacology 2016 41: 391-392; advance online publication, November 11, 2015; 10.1038/npp.2015.321 Full Text Circumspective Top Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed Margaret Haney and A Eden Evins Neuropsychopharmacology 2016 41: 393-401; advance online publication, August 19, 2015; 10.1038/npp.2015.251 Abstract | Full Text Original Articles Top Behavioral and Physiological Effects of a Novel Kappa-Opioid Receptor-Based DREADD in Rats Nathan J Marchant, Leslie R Whitaker, Jennifer M Bossert, Brandon K Harvey, Bruce T Hope, Konstantin Kaganovsky, Sweta Adhikary, Thomas E Prisinzano, Eyal Vardy, Bryan L Roth and Yavin Shaham Neuropsychopharmacology 2016 41: 402-409; advance online publication, May 28, 2015; 10.1038/npp.2015.149 Abstract | Full Text Impulsivity and Aggression in Female BPD and ADHD Patients: Association with ACC Glutamate and GABA Concentrations Gabriele Ende, Sylvia Cackowski, Julia Van Eijk, Markus Sack, Traute Demirakca, Nikolaus Kleindienst, Martin Bohus, Esther Sobanski, Annegret Krause-Utz and Christian Schmahl Neuropsychopharmacology 2016 41: 410-418; advance online publication, June 4, 2015; 10.1038/npp.2015.153 Abstract | Full Text Memantine Effects On Sensorimotor Gating and Mismatch Negativity in Patients with Chronic Psychosis Neal R Swerdlow, Savita Bhakta, Hsun-Hua Chou, Jo A Talledo, Bryan Balvaneda and Gregory A Light Neuropsychopharmacology 2016 41: 419-430; advance online publication, June 11, 2015; 10.1038/npp.2015.162 Abstract | Full Text Hunger Promotes Fear Extinction by Activation of an Amygdala Microcircuit OPEN Dilip Verma, James Wood, Gilliard Lach, Herbert Herzog, Guenther Sperk and Ramon Tasan Neuropsychopharmacology 2016 41: 431-439; advance online publication, June 11, 2015; 10.1038/npp.2015.163 Abstract | Full Text Disrupted-in-Schizophrenia-1 Attenuates Amyloid-β Generation and Cognitive Deficits in APP/PS1 Transgenic Mice by Reduction of β-Site APP-Cleaving Enzyme 1 Levels Qing-Shan Deng, Xing-Yu Dong, Hao Wu, Wang Wang, Zhao-Tao Wang, Jian-Wei Zhu, Chun-Feng Liu, Wei-Qiang Jia, Yan Zhang, Melitta Schachner, Quan-Hong Ma and Ru-Xiang Xu Neuropsychopharmacology 2016 41: 440-453; advance online publication, June 11, 2015; 10.1038/npp.2015.164 Abstract | Full Text Neural Correlates of Three Promising Endophenotypes of Depression: Evidence from the EMBARC Study Christian A Webb, Daniel G Dillon, Pia Pechtel, Franziska K Goer, Laura Murray, Quentin JM Huys, Maurizio Fava, Patrick J McGrath, Myrna Weissman, Ramin Parsey, Benji T Kurian, Phillip Adams, Sarah Weyandt, Joseph M Trombello, Bruce Grannemann, Crystal M Cooper, Patricia Deldin, Craig Tenke, Madhukar Trivedi, Gerard Bruder and Diego A Pizzagalli Neuropsychopharmacology 2016 41: 454-463; advance online publication, June 12, 2015; 10.1038/npp.2015.165 Abstract | Full Text Cocaine and Amphetamine Induce Overlapping but Distinct Patterns of AMPAR Plasticity in Nucleus Accumbens Medium Spiny Neurons Jakub Jedynak, Matthew Hearing, Anna Ingebretson, Stephanie R Ebner, Matthew Kelly, Rachel A Fischer, Saïd Kourrich and Mark J Thomas Neuropsychopharmacology 2016 41: 464-476; advance online publication, June 12, 2015; 10.1038/npp.2015.168 Abstract | Full Text Schizophrenia-Like Phenotype Inherited by the F2 Generation of a Gestational Disruption Model of Schizophrenia Stephanie M Perez, David D Aguilar, Jennifer L Neary, Melanie A Carless, Andrea Giuffrida and Daniel J Lodge Neuropsychopharmacology 2016 41: 477-486; advance online publication, June 12, 2015; 10.1038/npp.2015.169 Abstract | Full Text Single-Nucleotide Polymorphism of the FKBP5 Gene and Childhood Maltreatment as Predictors of Structural Changes in Brain Areas Involved in Emotional Processing in Depression Leonardo Tozzi, Angela Carballedo, Friedrich Wetterling, Hazel McCarthy, Veronica O'Keane, Michael Gill, Derrek Morris, Ciara Fahey, James Meaney and Thomas Frodl Neuropsychopharmacology 2016 41: 487-497; advance online publication, June 16, 2015; 10.1038/npp.2015.170 Abstract | Full Text Greater Insula White Matter Fiber Connectivity in Women Recovered from Anorexia Nervosa Megan E Shott, Tamara L Pryor, Tony T Yang and Guido K W Frank Neuropsychopharmacology 2016 41: 498-507; advance online publication, June 16, 2015; 10.1038/npp.2015.172 Abstract | Full Text Orexin-A and Endocannabinoid Activation of the Descending Antinociceptive Pathway Underlies Altered Pain Perception in Leptin Signaling Deficiency Luigia Cristino, Livio Luongo, Roberta Imperatore, Serena Boccella, Thorsten Becker, Giovanna Morello, Fabiana Piscitelli, Giuseppe Busetto, Sabatino Maione and Vincenzo Di Marzo Neuropsychopharmacology 2016 41: 508-520; advance online publication, June 17, 2015; 10.1038/npp.2015.173 Abstract | Full Text Altered Insula Activity during Visceral Interoception in Weight-Restored Patients with Anorexia Nervosa Kara L Kerr, Scott E Moseman, Jason A Avery, Jerzy Bodurka, Nancy L Zucker and W Kyle Simmons Neuropsychopharmacology 2016 41: 521-528; advance online publication, June 18, 2015; 10.1038/npp.2015.174 Abstract | Full Text Occupancy of Dopamine D3 and D2 Receptors by Buspirone: A [11C]-(+)-PHNO PET Study in Humans Bernard Le Foll, Doris Payer, Patricia Di Ciano, Mihail Guranda, Shinichiro Nakajima, Junchao Tong, Esmaeil Mansouri, Alan A Wilson, Sylvain Houle, Jeff H Meyer, Ariel Graff-Guerrero and Isabelle Boileau Neuropsychopharmacology 2016 41: 529-537; advance online publication, June 19, 2015; 10.1038/npp.2015.177 Abstract | Full Text Synaptic microRNAs Coordinately Regulate Synaptic mRNAs: Perturbation by Chronic Alcohol Consumption Dana Most, Courtney Leiter, Yuri A Blednov, R Adron Harris and R Dayne Mayfield Neuropsychopharmacology 2016 41: 538-548; advance online publication, June 24, 2015; 10.1038/npp.2015.179 Abstract | Full Text Clinically Relevant Pharmacological Strategies That Reverse MDMA-Induced Brain Hyperthermia Potentiated by Social Interaction Eugene A Kiyatkin, Suelynn Ren, Ken T Wakabayashi, Michael H Baumann and Yavin Shaham Neuropsychopharmacology 2016 41: 549-559; advance online publication, June 24, 2015; 10.1038/npp.2015.182 Abstract | Full Text Dissociating Motivational From Physiological Withdrawal in Alcohol Dependence: Role of Central Amygdala κ-Opioid Receptors Jessica L Kissler and Brendan M Walker Neuropsychopharmacology 2016 41: 560-567; advance online publication, June 24, 2015; 10.1038/npp.2015.183 Abstract | Full Text Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains Michael R Weed, Mark Bookbinder, Joseph Polino, Deborah Keavy, Rudolf N Cardinal, Jean Simmermacher-Mayer, Fu-ni L Cometa, Dalton King, Srinivasan Thangathirupathy, John E Macor and Linda J Bristow Neuropsychopharmacology 2016 41: 568-577; advance online publication, June 24, 2015; 10.1038/npp.2015.184 Abstract | Full Text Prenatal Nicotine Exposure Impairs the Proliferation of Neuronal Progenitors, Leading to Fewer Glutamatergic Neurons in the Medial Prefrontal Cortex Yuki Aoyama, Kazuya Toriumi, Akihiro Mouri, Tomoya Hattori, Eriko Ueda, Akane Shimato, Nami Sakakibara, Yuka Soh, Takayoshi Mamiya, Taku Nagai, Hyoung-Chun Kim, Masayuki Hiramatsu, Toshitaka Nabeshima and Kiyofumi Yamada Neuropsychopharmacology 2016 41: 578-589; advance online publication, June 24, 2015; 10.1038/npp.2015.186 Abstract | Full Text Effects of Escitalopram Administration on Face Processing in Intermittent Explosive Disorder: An fMRI Study Henk Cremers, Royce Lee, Sarah Keedy, K Luan Phan and Emil Coccaro Neuropsychopharmacology 2016 41: 590-597; advance online publication, June 24, 2015; 10.1038/npp.2015.187 Abstract | Full Text Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model A Ghoshal, J M Rook, J W Dickerson, G N Roop, R D Morrison, N Jalan-Sakrikar, A Lamsal, M J Noetzel, M S Poslusney, M R Wood, B J Melancon, S R Stauffer, Z Xiang, J S Daniels, C M Niswender, C K Jones, C W Lindsley and P J Conn Neuropsychopharmacology 2016 41: 598-610; advance online publication, June 25, 2015; 10.1038/npp.2015.189 Abstract | Full Text Emotion Regulatory Brain Function and SSRI Treatment in PTSD: Neural Correlates and Predictors of Change Annmarie MacNamara, Christine A Rabinak, Amy E Kennedy, Daniel A Fitzgerald, Israel Liberzon, Murray B Stein and K Luan Phan Neuropsychopharmacology 2016 41: 611-618; advance online publication, June 26, 2015; 10.1038/npp.2015.190 Abstract | Full Text Withdrawal from Acute Amphetamine Induces an Amygdala-Driven Attenuation of Dopamine Neuron Activity: Reversal by Ketamine Pauline Belujon, Nicole L Jakobowski, Hannah K Dollish and Anthony A Grace Neuropsychopharmacology 2016 41: 619-627; advance online publication, July 1, 2015; 10.1038/npp.2015.191 Abstract | Full Text Brain Activity During Cocaine Craving and Gambling Urges: An fMRI Study Hedy Kober, Cheryl M Lacadie, Bruce E Wexler, Robert T Malison, Rajita Sinha and Marc N Potenza Neuropsychopharmacology 2016 41: 628-637; advance online publication, June 29, 2015; 10.1038/npp.2015.193 Abstract | Full Text Comparing Pharmacological Modulation of Sensory Gating in Healthy Humans and Rats: The Effects of Reboxetine and Haloperidol Louise Witten, Jesper Frank Bastlund, Birte Y Glenthøj, Christoffer Bundgaard, Björn Steiniger-Brach, Arne Mørk and Bob Oranje Neuropsychopharmacology 2016 41: 638-645; advance online publication, July 1, 2015; 10.1038/npp.2015.194 Abstract | Full Text Choosing Under the Influence: A Drug-Specific Mechanism by Which the Setting Controls Drug Choices in Rats Youna Vandaele, Lauriane Cantin, Fuschia Serre, Caroline Vouillac-Mendoza and Serge H Ahmed Neuropsychopharmacology 2016 41: 646-657; advance online publication, July 1, 2015; 10.1038/npp.2015.195 Abstract | Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.